Clinical trials: Aldosteronism
Primary Aldosteronism
The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach
Primary Aldosteronism (PA) is a clinical syndrome characterized by the autonomous overproduction of aldosterone by the adrenal cortex's zona glomerulosa, leading to hypertension, elevated aldosterone levels, and suppressed renin…
- Trial name
- NCT06737848
- Testing
- Single catheter adrenal vein sampling, Double catheters adrenal vein sampling
- Volunteers
- 70 people
- Sponsor
- Army Medical University, China
Primary Aldosteronism
Primary Aldosteronism LC-MS/MS-specific Cutoffs
Aims to evaluation the LC-MS/MS-specific cutoffs of PA screening and CCT test.
- Trial name
- PM (NCT05959863)
- Testing
- Captopril Challenge Test
- Where
- 2 sites in China
- Volunteers
- 396 people
- Sponsor
- Chongqing Medical University
Primary Aldosteronism
DP13 - A Phase II Study in Patients With Primary Aldosteronism
The purpose of the present phase II study is to determine whether DP13 displays the clinical safety and efficacy profile to support further development in patients with primary aldosteronism.
- Trial name
- NCT04007406
- Testing
- dexfadrostat phosphate
- Where
- Italy
- Volunteers
- 35 people
- Sponsor
- Damian Pharma AG
Primary Aldosteronism, Statin
Statin Combined with Amlodipine Treats Primary Aldosteronism
The drug treatment for primary aldosteronism (PA) is limited and difficult to improve long-term cardiovascular outcomes. This study plans to enroll patients with primary aldosteronism and randomly divide into 3 groups: scheme 1…
- Conditions
- Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension
- Trial name
- STOP-PA (NCT06523465)
- Testing
- Simvastatin combined with Amlodipine besylate, Simvastatin combined with Spironolactone and Amlodipine besylate., Amlodipine besylate combined Spironolactone
- Where
- China
- Volunteers
- 180 people
- Sponsor
- Third Military Medical University
Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Accuracy of 68Ga-Pentixafor PET/CT for Subtypting Diagnosis in Patients With Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
To evaluate the accuracy of 68Ga-Pentixafor PET-CT in the classification diagnosis of primary aldosteronism concurrent with autonomous cortisol secretion patient, using AVS and/or postoperative remission as the reference standard…
- Trial name
- ABOARD (NCT06635993)
- Testing
- 68Ga-Pentixafor PET/CT
- Where
- China
- Volunteers
- 97 people
- Sponsor
- Qifu Li
Primary Aldosteronism
Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism
1. Aim to investigate the pathological feature of UPA in Asians 2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians. 3.
- Trial name
- NCT06597630
- Testing
- Tissue specimens were stained by histopathology of hematoxylin-eosin
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Qifu Li
Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Non Invasive Imaging Methods for Detecting PA：a Clinical PET Study of 18F-Pentixather
Primary aldosteronism (PA) is the most common endocrine cause of hypertension. 68Ga-pentixafor PET/CT possesses a relatively high sensitivity and specificity for Aldosterone producing adenoma (APA) detection.
- Trial name
- NCT06581744
- Testing
- [18F]AlF-NOTA-Pentixather
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Fangfang Sun
Primary Aldosteronism
New Screening and Diagnostic Cut-off Points of PA Patients
This study aims to establish the screening and diagnostic cut-off points for primary aldosteronism patients by a novel small molecule "sandwich method" aldosterone and renin chemiluminescent immunoassay.
- Trial name
- NCT06571084
- Where
- China
- Volunteers
- 770 people
- Sponsor
- China National Center for Cardiovascular Diseases
Primary Aldosteronism, Hypertension
Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
Primary aldosteronism (PA) is one of the most common cause of endocrine and resistant hypertension. Current studies have shown that the activation of the renin-angiotensin-aldosterone system (RAAS) and the increased sympathetic…
- Trial name
- NCT04409431
- Testing
- Endovascular chemical Ablation of Adrenal Gland
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Third Military Medical University
Primary Aldosteronism
Primary Aldosteronism: Prospective Screening Registry in China
1. Study name: A prospective study of the incidence and outcomes of Primary aldosteronism in Chinese hypertensive patients 2. Rationale: Unlike essential hypertension, secondary hypertension is caused by certain defined diseases…
- Trial name
- NCT04020783
- Testing
- NO Intervention
- Where
- China
- Volunteers
- 10,000 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Primary Aldosteronism
Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism
This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting…
- Trial name
- NCT06534268
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- Ruijin Hospital
Essential Hypertension, Liver Cancer
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them.
- Conditions
- Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer
- Trial name
- NCT05638269
- Testing
- no intervention
- Where
- 50 sites in China
- Volunteers
- 12,000 people, healthy volunteers welcome
- Sponsor
- Zhujiang Hospital
Primary Aldosteronism
Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism
This study is to evaluate the accuracy of a novel radiopharmaceutical tracer, para-chloro-2-[18F]fluoroethyl etomidate (CETO), used with positron emission tomography (PET) and computed tomography (CT), as a way to subtype…
- Trial name
- NCT05472493
- Testing
- [18-F]CETO
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- University of Calgary
Primary Aldosteronism, Super Selective Adrenal Arterial Embolization
Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)
The objective of this study was to evaluate the efficacy and safety of adrenal vein blood extraction for primary aldosteronism classification and adrenal artery embolization in the treatment of primary aldosteronism, to provide…
- Trial name
- NCT06513676
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Xinjiang Medical University
Primary Aldosteronism, Essential Hypertension
The Plasma Metabolomics Profiling of Primary Aldosteronism
Primary aldosteronism (PA), characterized by overt renin-independent aldosterone production, is the most common form endocrine hypertension.
- Conditions
- Primary Aldosteronism, Essential Hypertension, Idiopathic Aldosteronism, Aldosterone-producing Adenoma
- Trial name
- NCT06500000
- Testing
- liquid chromatography-mass spectrometry (LC/MS)
- Where
- China
- Volunteers
- 95 people
- Sponsor
- Third Military Medical University
Mineralocorticoid Excess, Primary Aldosteronism
Dynamic Hormone Profiling and Multimodal Data Capture in Primary Aldosteronism
This study is a observational study applying 24-hour microdialysis methodology to perform dynamic multisteroid adrenal hormone profiling of patients with suspected or confirmed PA.
- Conditions
- Mineralocorticoid Excess, Primary Aldosteronism, Hypercortisolism
- Trial name
- NCT06495983
- Testing
- dynamic microdialysis sampling
- Where
- Norway
- Volunteers
- 80 people
- Sponsor
- Haukeland University Hospital
Primary Aldosteronism, Endocrine Hypertension
Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
The goal of this pilot, open-label prospective study is to evaluate if the effect of calcium channel blockade on plasma aldosterone levels in people with primary aldosteronism (PA) is due primarily to Cav1.3 blockade.
- Trial name
- NCT05686993
- Testing
- Cinnarizine, NIFEdipine ER
- Where
- United Kingdom
- Volunteers
- 15 people
- Sponsor
- Queen Mary University of London
Primary Aldosteronism
Evaluation of [68Ga]Ga-PentixaFor PET Imaging for the Identification of Unilateral Adrenal Secretion of ALdosterON in Patients With Primary Aldosteronism
PentixaFor radiolabeled with 68Gallium (68Ga) is a radiopharmaceutical targeting the CXC chemokine receptor 4 (CXCR4) receptor. The CXCR4 receptor is expressed in zona glomerulosa of the adrenal cortex and in aldosterone…
- Trial name
- PENTALON (NCT06478875)
- Testing
- [68Ga]Ga-PentixaFor PET imaging
- Where
- 2 sites in France
- Volunteers
- 20 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Primary Aldosteronism
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
To study the efficacy and safety of finerenone in patients with primary aldosteronism
- Trial name
- NCT05924620
- Testing
- finerenone
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Chongqing Medical University
Primary Aldosteronism
Preoperative Supine Time for Adrenal Venous Sampling
This study aim to understand whether the length of preoperative supine time would affect the AVS outcome.
- Trial name
- PSTAVS (NCT05658705)
- Testing
- 15-min supine time, 2-hour supine time
- Where
- China
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine